0.108
1.82%
-0.002
After Hours:
.11
0.002
+1.85%
Cns Pharmaceuticals Inc (CNSP) Stock Split History
Cns Pharmaceuticals Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on November 29, 2022 with the ratio of 1-for-30, meaning that for 30 shares of CNSP owned pre-split, shareholders then owned 1 share. The most recent stock split took place on June 05, 2024 on a 1-for-50 basis.
These actions have increased CNSP stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Cns Pharmaceuticals Inc's total market capitalization.
For more detailed information of Cns Pharmaceuticals Inc's stock splits, view the table below:
These actions have increased CNSP stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Cns Pharmaceuticals Inc's total market capitalization.
For more detailed information of Cns Pharmaceuticals Inc's stock splits, view the table below:
CNSP stock split list
Date | Split Ratio |
---|---|
2024-06-05 | 1 - for - 50 |
2022-11-29 | 1 - for - 30 |
Will Cns Pharmaceuticals Inc Stock Split in 2024?
The answer will depend on the decisions of the company's managers and market volatility. Cns Pharmaceuticals Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when CNSP stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Cns Pharmaceuticals Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Stock Splits of Industry Leaders
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):